UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Toward a more accurate estimate of the prevalence of hepatitis C in the United States

Hepatology (Baltimore, Md.), 2015-11, Vol.62 (5), p.1353-1363

2015

Volltextzugriff (PDF)

The impact of the COVID-19 pandemic on harm reduction services in Spain

Harm reduction journal, 2020-11, Vol.17 (1), p.87-87, Article 87

2020

Volltextzugriff (PDF)

Management of Hepatitis C Virus/HIV Coinfection Among People Who Use Drugs in the Era of Direct-Acting Antiviral—Based Therapy

Clinical infectious diseases, 2013-08, Vol.57 (suppl_2), p.S118-S124

2013

Volltextzugriff (PDF)

The path to hepatitis C elimination: who are we leaving behind and why?

Journal of the International AIDS Society, 2023-07, Vol.26 (7), p.e26136-n/a

2023

Volltextzugriff (PDF)

Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settings

Journal of hepatology, 2014-11, Vol.61 (1), p.S132-S138

2014

Volltextzugriff (PDF)

Global hepatitis C elimination: an investment framework

The lancet. Gastroenterology & hepatology, 2020-10, Vol.5 (10), p.927-939

2020

Volltextzugriff (PDF)

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

Annals of internal medicine, 2015-08, Vol.163 (3), p.215-223

2015

Volltextzugriff (PDF)

A path to eradication of hepatitis C in low- and middle-income countries

Antiviral research, 2015-07, Vol.119, p.89-96

2015

Volltextzugriff (PDF)

HIV Coinfection With Hepatitis C Virus: Evolving Epidemiology and Treatment Paradigms

Clinical infectious diseases, 2012-07, Vol.55 (suppl 1), p.S33-S42

2012

Volltextzugriff (PDF)

Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden

The International journal of drug policy, 2023-01, Vol.111, Article 101670

2023

Volltextzugriff (PDF)

The promise of treatment as prevention for hepatitis C: Meeting the needs of people who inject drugs?

The International journal of drug policy, 2015-10, Vol.26 (10), p.963-969

2015

Volltextzugriff (PDF)

Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy

Clinical infectious diseases, 2020-10, Vol.71 (7), p.e115-e124

2020

Volltextzugriff (PDF)

Comment on the updated AASLD practice guidelines for the diagnosis, management, and treatment of hepatitis C: Treating active drug users

Hepatology (Baltimore, Md.), 2009-07, Vol.50 (1), p.323-324

2009

Volltextzugriff (PDF)

Abstract P117: Successful Comprehensive Management of Labile Severe Hypertension With Zero-Salt Diet, Stress Reduction, and Antihypertensive Combination of Sacubitril-Valsartan and Nebivolol

Hypertension (Dallas, Tex. 1979), 2019-09, Vol.74 (Suppl_1)

2019

Volltextzugriff (PDF)

Recommendations for the management of hepatitis C virus infection among people who inject drugs

The International journal of drug policy, 2015-10, Vol.26 (10), p.1028-1038

2015

Volltextzugriff (PDF)

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

The lancet. Gastroenterology & hepatology, 2018-03, Vol.3 (3), p.153-161

2018

Volltextzugriff (PDF)

Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs

Clinical infectious diseases, 2013-08, Vol.57 (suppl 2), p.S129-S137

2013

Volltextzugriff (PDF)

Hepatitis delta in HIV/hepatitis B coinfection: A call for action

HIV medicine, 2024-03, Vol.25 (3), p.319-321

2024

Volltextzugriff (PDF)

Community-Led Monitoring: When Community Data Drives Implementation Strategies

Current HIV/AIDS reports, 2020-10, Vol.17 (5), p.415-421

2020

Volltextzugriff (PDF)

Why it’s time to say goodbye to stavudine ... everywhere

Southern African journal of HIV medicine, 2012-03, Vol.13 (43), p.17-19

2012

Volltextzugriff (PDF)

Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data?

Journal of hepatology, 2015-10, Vol.63 (4), p.779-782

2015

Volltextzugriff (PDF)

UNITAID can address HCV/HIV co-infection

The Lancet (British edition), 2013-02, Vol.381 (9867), p.628-628

2013

Volltextzugriff (PDF)

Innovative strategies for the elimination of viral hepatitis at a national level: A country case series

Liver international, 2019-10, Vol.39 (10), p.1818-1836

2019

Volltextzugriff (PDF)

Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study

Journal of hepatology, 2024-05, Vol.80 (5), p.702-713

2024

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Englisch
(87)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(49)
Humans
(47)
Antiviral Agents - Therapeutic Use
(24)
Hepatitis C
(19)
Hepatitis C - Drug Therapy
(19)
Hepatitis
(16)
Infectious Diseases
(16)
Male
(13)
Gastroenterology & Hepatology
(12)
Hiv
(12)
Substance Abuse, Intravenous - Complications
(11)
Hepatitis C - Complications
(10)
Hiv Infections - Complications
(10)
Human Immunodeficiency Virus
(10)
Female
(9)
Hepatitis C, Chronic - Drug Therapy
(9)
Drug Use
(8)
Hepatitis C Virus
(8)
Infections
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Toward a more accurate estimate of the prevalence of hepatitis C in the United States

The impact of the COVID-19 pandemic on harm reduction services in Spain

Management of Hepatitis C Virus/HIV Coinfection Among People Who Use Drugs in the Era of Direct-Acting Antiviral—Based Therapy

The path to hepatitis C elimination: who are we leaving behind and why?

Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settings

Global hepatitis C elimination: an investment framework

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

A path to eradication of hepatitis C in low- and middle-income countries

Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

HIV Coinfection With Hepatitis C Virus: Evolving Epidemiology and Treatment Paradigms

Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden

The promise of treatment as prevention for hepatitis C: Meeting the needs of people who inject drugs?

Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy

Comment on the updated AASLD practice guidelines for the diagnosis, management, and treatment of hepatitis C: Treating active drug users

Abstract P117: Successful Comprehensive Management of Labile Severe Hypertension With Zero-Salt Diet, Stress Reduction, and Antihypertensive Combination of Sacubitril-Valsartan and Nebivolol

Recommendations for the management of hepatitis C virus infection among people who inject drugs

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs

Hepatitis delta in HIV/hepatitis B coinfection: A call for action

Community-Led Monitoring: When Community Data Drives Implementation Strategies

Why it’s time to say goodbye to stavudine ... everywhere

Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data?

UNITAID can address HCV/HIV co-infection

Innovative strategies for the elimination of viral hepatitis at a national level: A country case series

Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study

Suchergebnisse filtern